Click for best price
PRRS Vaccines Market Size, Share 2022
Market Analysis and Insights: Global PRRS Vaccines Market
The global PRRS Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PRRS Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PRRS Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PRRS Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PRRS Vaccines market.
Global PRRS Vaccines Scope and Market Size
PRRS Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global PRRS Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the PRRS Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes PRRS Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of PRRS Vaccines, with price, sales, revenue, and global market share of PRRS Vaccines from 2019 to 2022.
Chapter 3, the PRRS Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PRRS Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the PRRS Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of PRRS Vaccines.
Chapter 13, 14, and 15, to describe PRRS Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 PRRS Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States PRRS Vaccines Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 PRRS Vaccines Product Introduction
1.2 Global PRRS Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global PRRS Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global PRRS Vaccines Sales in Volume for the Year 2017-2028
1.3 United States PRRS Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States PRRS Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States PRRS Vaccines Sales in Volume for the Year 2017-2028
1.4 PRRS Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States PRRS Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of PRRS Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 PRRS Vaccines Market Dynamics
1.5.1 PRRS Vaccines Industry Trends
1.5.2 PRRS Vaccines Market Drivers
1.5.3 PRRS Vaccines Market Challenges
1.5.4 PRRS Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 PRRS Vaccines Market Segment by Type
2.1.1 Live Vaccines
2.1.2 Killed Vaccines
2.2 Global PRRS Vaccines Market Size by Type
2.2.1 Global PRRS Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global PRRS Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global PRRS Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States PRRS Vaccines Market Size by Type
2.3.1 United States PRRS Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States PRRS Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States PRRS Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 PRRS Vaccines Market Segment by Application
3.1.1 Government Tender
3.1.2 Market Sales
3.2 Global PRRS Vaccines Market Size by Application
3.2.1 Global PRRS Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global PRRS Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global PRRS Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States PRRS Vaccines Market Size by Application
3.3.1 United States PRRS Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States PRRS Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States PRRS Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global PRRS Vaccines Competitor Landscape by Company
4.1 Global PRRS Vaccines Market Size by Company
4.1.1 Top Global PRRS Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global PRRS Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global PRRS Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global PRRS Vaccines Price by Manufacturer (2017-2022)
4.2 Global PRRS Vaccines Concentration Ratio (CR)
4.2.1 PRRS Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of PRRS Vaccines in 2021
4.2.3 Global PRRS Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global PRRS Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global PRRS Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers PRRS Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into PRRS Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States PRRS Vaccines Market Size by Company
4.5.1 Top PRRS Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States PRRS Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States PRRS Vaccines Sales by Players (2020, 2021 & 2022)
5 Global PRRS Vaccines Market Size by Region
5.1 Global PRRS Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global PRRS Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global PRRS Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global PRRS Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global PRRS Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global PRRS Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global PRRS Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America PRRS Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific PRRS Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific PRRS Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe PRRS Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America PRRS Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa PRRS Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa PRRS Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 CAHIC
7.1.1 CAHIC Corporation Information
7.1.2 CAHIC Description and Business Overview
7.1.3 CAHIC PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CAHIC PRRS Vaccines Products Offered
7.1.5 CAHIC Recent Development
7.2 Merial
7.2.1 Merial Corporation Information
7.2.2 Merial Description and Business Overview
7.2.3 Merial PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merial PRRS Vaccines Products Offered
7.2.5 Merial Recent Development
7.3 MSD Animal Health
7.3.1 MSD Animal Health Corporation Information
7.3.2 MSD Animal Health Description and Business Overview
7.3.3 MSD Animal Health PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 MSD Animal Health PRRS Vaccines Products Offered
7.3.5 MSD Animal Health Recent Development
7.4 Chopper Biology
7.4.1 Chopper Biology Corporation Information
7.4.2 Chopper Biology Description and Business Overview
7.4.3 Chopper Biology PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Chopper Biology PRRS Vaccines Products Offered
7.4.5 Chopper Biology Recent Development
7.5 Ceva
7.5.1 Ceva Corporation Information
7.5.2 Ceva Description and Business Overview
7.5.3 Ceva PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Ceva PRRS Vaccines Products Offered
7.5.5 Ceva Recent Development
7.6 ChengDu Tecbond
7.6.1 ChengDu Tecbond Corporation Information
7.6.2 ChengDu Tecbond Description and Business Overview
7.6.3 ChengDu Tecbond PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 ChengDu Tecbond PRRS Vaccines Products Offered
7.6.5 ChengDu Tecbond Recent Development
7.7 Veterinary
7.7.1 Veterinary Corporation Information
7.7.2 Veterinary Description and Business Overview
7.7.3 Veterinary PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Veterinary PRRS Vaccines Products Offered
7.7.5 Veterinary Recent Development
7.8 Ringpu Biology
7.8.1 Ringpu Biology Corporation Information
7.8.2 Ringpu Biology Description and Business Overview
7.8.3 Ringpu Biology PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Ringpu Biology PRRS Vaccines Products Offered
7.8.5 Ringpu Biology Recent Development
7.9 Qilu Animal
7.9.1 Qilu Animal Corporation Information
7.9.2 Qilu Animal Description and Business Overview
7.9.3 Qilu Animal PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Qilu Animal PRRS Vaccines Products Offered
7.9.5 Qilu Animal Recent Development
7.10 DHN
7.10.1 DHN Corporation Information
7.10.2 DHN Description and Business Overview
7.10.3 DHN PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 DHN PRRS Vaccines Products Offered
7.10.5 DHN Recent Development
7.11 CAVAC
7.11.1 CAVAC Corporation Information
7.11.2 CAVAC Description and Business Overview
7.11.3 CAVAC PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 CAVAC PRRS Vaccines Products Offered
7.11.5 CAVAC Recent Development
7.12 Komipharm
7.12.1 Komipharm Corporation Information
7.12.2 Komipharm Description and Business Overview
7.12.3 Komipharm PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Komipharm Products Offered
7.12.5 Komipharm Recent Development
7.13 Agrovet
7.13.1 Agrovet Corporation Information
7.13.2 Agrovet Description and Business Overview
7.13.3 Agrovet PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Agrovet Products Offered
7.13.5 Agrovet Recent Development
7.14 Bioveta
7.14.1 Bioveta Corporation Information
7.14.2 Bioveta Description and Business Overview
7.14.3 Bioveta PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Bioveta Products Offered
7.14.5 Bioveta Recent Development
7.15 Jinyu Bio-Technology
7.15.1 Jinyu Bio-Technology Corporation Information
7.15.2 Jinyu Bio-Technology Description and Business Overview
7.15.3 Jinyu Bio-Technology PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Jinyu Bio-Technology Products Offered
7.15.5 Jinyu Bio-Technology Recent Development
7.16 Institutul Pasteur
7.16.1 Institutul Pasteur Corporation Information
7.16.2 Institutul Pasteur Description and Business Overview
7.16.3 Institutul Pasteur PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Institutul Pasteur Products Offered
7.16.5 Institutul Pasteur Recent Development
7.17 MVP
7.17.1 MVP Corporation Information
7.17.2 MVP Description and Business Overview
7.17.3 MVP PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.17.4 MVP Products Offered
7.17.5 MVP Recent Development
7.18 Tecon
7.18.1 Tecon Corporation Information
7.18.2 Tecon Description and Business Overview
7.18.3 Tecon PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Tecon Products Offered
7.18.5 Tecon Recent Development
7.19 Zoetis
7.19.1 Zoetis Corporation Information
7.19.2 Zoetis Description and Business Overview
7.19.3 Zoetis PRRS Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Zoetis Products Offered
7.19.5 Zoetis Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 PRRS Vaccines Industry Chain Analysis
8.2 PRRS Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 PRRS Vaccines Distributors
8.3 PRRS Vaccines Production Mode & Process
8.4 PRRS Vaccines Sales and Marketing
8.4.1 PRRS Vaccines Sales Channels
8.4.2 PRRS Vaccines Distributors
8.5 PRRS Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. PRRS Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. PRRS Vaccines Market Trends
Table 3. PRRS Vaccines Market Drivers
Table 4. PRRS Vaccines Market Challenges
Table 5. PRRS Vaccines Market Restraints
Table 6. Global PRRS Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States PRRS Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global PRRS Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States PRRS Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top PRRS Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global PRRS Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global PRRS Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global PRRS Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global PRRS Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global PRRS Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global PRRS Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global PRRS Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PRRS Vaccines as of 2021)
Table 18. Top Players of PRRS Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers PRRS Vaccines Product Type
Table 20. Date of International Manufacturers Enter into PRRS Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top PRRS Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States PRRS Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States PRRS Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States PRRS Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States PRRS Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global PRRS Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global PRRS Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global PRRS Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global PRRS Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global PRRS Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America PRRS Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America PRRS Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific PRRS Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific PRRS Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe PRRS Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe PRRS Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America PRRS Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa PRRS Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa PRRS Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa PRRS Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. CAHIC Corporation Information
Table 43. CAHIC Description and Business Overview
Table 44. CAHIC PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. CAHIC PRRS Vaccines Product
Table 46. CAHIC Recent Development
Table 47. Merial Corporation Information
Table 48. Merial Description and Business Overview
Table 49. Merial PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Merial Product
Table 51. Merial Recent Development
Table 52. MSD Animal Health Corporation Information
Table 53. MSD Animal Health Description and Business Overview
Table 54. MSD Animal Health PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. MSD Animal Health Product
Table 56. MSD Animal Health Recent Development
Table 57. Chopper Biology Corporation Information
Table 58. Chopper Biology Description and Business Overview
Table 59. Chopper Biology PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Chopper Biology Product
Table 61. Chopper Biology Recent Development
Table 62. Ceva Corporation Information
Table 63. Ceva Description and Business Overview
Table 64. Ceva PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Ceva Product
Table 66. Ceva Recent Development
Table 67. ChengDu Tecbond Corporation Information
Table 68. ChengDu Tecbond Description and Business Overview
Table 69. ChengDu Tecbond PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. ChengDu Tecbond Product
Table 71. ChengDu Tecbond Recent Development
Table 72. Veterinary Corporation Information
Table 73. Veterinary Description and Business Overview
Table 74. Veterinary PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Veterinary Product
Table 76. Veterinary Recent Development
Table 77. Ringpu Biology Corporation Information
Table 78. Ringpu Biology Description and Business Overview
Table 79. Ringpu Biology PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Ringpu Biology Product
Table 81. Ringpu Biology Recent Development
Table 82. Qilu Animal Corporation Information
Table 83. Qilu Animal Description and Business Overview
Table 84. Qilu Animal PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Qilu Animal Product
Table 86. Qilu Animal Recent Development
Table 87. DHN Corporation Information
Table 88. DHN Description and Business Overview
Table 89. DHN PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. DHN Product
Table 91. DHN Recent Development
Table 92. CAVAC Corporation Information
Table 93. CAVAC Description and Business Overview
Table 94. CAVAC PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. CAVAC Product
Table 96. CAVAC Recent Development
Table 97. Komipharm Corporation Information
Table 98. Komipharm Description and Business Overview
Table 99. Komipharm PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Komipharm Product
Table 101. Komipharm Recent Development
Table 102. Agrovet Corporation Information
Table 103. Agrovet Description and Business Overview
Table 104. Agrovet PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Agrovet Product
Table 106. Agrovet Recent Development
Table 107. Bioveta Corporation Information
Table 108. Bioveta Description and Business Overview
Table 109. Bioveta PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Bioveta Product
Table 111. Bioveta Recent Development
Table 112. Jinyu Bio-Technology Corporation Information
Table 113. Jinyu Bio-Technology Description and Business Overview
Table 114. Jinyu Bio-Technology PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Jinyu Bio-Technology Product
Table 116. Jinyu Bio-Technology Recent Development
Table 117. Institutul Pasteur Corporation Information
Table 118. Institutul Pasteur Description and Business Overview
Table 119. Institutul Pasteur PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Institutul Pasteur Product
Table 121. Institutul Pasteur Recent Development
Table 122. MVP Corporation Information
Table 123. MVP Description and Business Overview
Table 124. MVP PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. MVP Product
Table 126. MVP Recent Development
Table 127. Tecon Corporation Information
Table 128. Tecon Description and Business Overview
Table 129. Tecon PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Tecon Product
Table 131. Tecon Recent Development
Table 132. Zoetis Corporation Information
Table 133. Zoetis Description and Business Overview
Table 134. Zoetis PRRS Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Zoetis Product
Table 136. Zoetis Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. PRRS Vaccines Customers List
Table 140. PRRS Vaccines Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. PRRS Vaccines Product Picture
Figure 2. Global PRRS Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global PRRS Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global PRRS Vaccines Sales 2017-2028 (K Units)
Figure 5. United States PRRS Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States PRRS Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States PRRS Vaccines Sales 2017-2028 (K Units)
Figure 8. United States PRRS Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States PRRS Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. PRRS Vaccines Report Years Considered
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Killed Vaccines
Figure 13. Global PRRS Vaccines Market Share by Type in 2022 & 2028
Figure 14. Global PRRS Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global PRRS Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 16. Global PRRS Vaccines Sales by Type (2017-2028) & (K Units)
Figure 17. Global PRRS Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global PRRS Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States PRRS Vaccines Market Share by Type in 2022 & 2028
Figure 20. United States PRRS Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States PRRS Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 22. United States PRRS Vaccines Sales by Type (2017-2028) & (K Units)
Figure 23. United States PRRS Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States PRRS Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Government Tender
Figure 26. Product Picture of Market Sales
Figure 27. Global PRRS Vaccines Market Share by Application in 2022 & 2028
Figure 28. Global PRRS Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global PRRS Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 30. Global PRRS Vaccines Sales by Application (2017-2028) & (K Units)
Figure 31. Global PRRS Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global PRRS Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States PRRS Vaccines Market Share by Application in 2022 & 2028
Figure 34. United States PRRS Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States PRRS Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 36. United States PRRS Vaccines Sales by Application (2017-2028) & (K Units)
Figure 37. United States PRRS Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States PRRS Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America PRRS Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America PRRS Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe PRRS Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe PRRS Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific PRRS Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific PRRS Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America PRRS Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America PRRS Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa PRRS Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa PRRS Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E PRRS Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. PRRS Vaccines Value Chain
Figure 73. PRRS Vaccines Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
